Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients... Show more
ORINY saw its Momentum Indicator move above the 0 level on January 26, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator turned positive. In of the 42 cases, the stock moved higher in the following days. The odds of a move higher are at .
The Moving Average Convergence Divergence (MACD) for ORINY just turned positive on January 26, 2026. Looking at past instances where ORINY's MACD turned positive, the stock continued to rise in of 31 cases over the following month. The odds of a continued upward trend are .
ORINY moved above its 50-day moving average on December 26, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ORINY crossed bullishly above the 50-day moving average on December 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The 50-day moving average for ORINY moved above the 200-day moving average on January 21, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 140 cases where ORINY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for ORINY moved out of overbought territory on January 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
ORINY broke above its upper Bollinger Band on January 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.533) is normal, around the industry mean (9.533). P/E Ratio (30.976) is within average values for comparable stocks, (24.433). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.907). Dividend Yield (0.023) settles around the average of (0.025) among similar stocks. P/S Ratio (5.963) is also within normal values, averaging (3.990).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORINY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
Industry PharmaceuticalsMajor
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UVXY | 36.72 | 2.09 | +6.04% |
| ProShares Ultra VIX Short-Term Futures | |||
| IQM | 92.88 | 0.87 | +0.95% |
| Franklin Intelligent Machines ETF | |||
| DES | 36.47 | 0.22 | +0.61% |
| WisdomTree US SmallCap Dividend ETF | |||
| QMID | 28.70 | N/A | N/A |
| WisdomTree U.S. Mid Cap Quality Gr | |||
| QTPI | 25.73 | -0.02 | -0.06% |
| North Square Rcim Tax-Advantaged Preferred And Income Securities ETF | |||
A.I.dvisor tells us that ORINY and GIKLY have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORINY and GIKLY's prices will move in lockstep.
| Ticker / NAME | Correlation To ORINY | 1D Price Change % | ||
|---|---|---|---|---|
| ORINY | 100% | +0.53% | ||
| GIKLY - ORINY | 9% Poorly correlated | -0.45% | ||
| GLAXF - ORINY | 6% Poorly correlated | N/A | ||
| NVSEF - ORINY | 5% Poorly correlated | -2.73% | ||
| OPHLY - ORINY | 3% Poorly correlated | +3.46% | ||
| MAYNF - ORINY | 0% Poorly correlated | +5.24% | ||
More | ||||